ID: ALA5088853

Max Phase: Preclinical

Molecular Formula: C12H17NOS

Molecular Weight: 223.34

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  c1cc2c(s1)[C@H](CN1CCCC1)OCC2

Standard InChI:  InChI=1S/C12H17NOS/c1-2-6-13(5-1)9-11-12-10(3-7-14-11)4-8-15-12/h4,8,11H,1-3,5-7,9H2/t11-/m0/s1

Standard InChI Key:  FWJXTGZOPGGPFU-NSHDSACASA-N

Associated Targets(Human)

Trace amine-associated receptor 1 1397 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 223.34Molecular Weight (Monoisotopic): 223.1031AlogP: 2.46#Rotatable Bonds: 2
Polar Surface Area: 12.47Molecular Species: BASEHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.75CX LogP: 2.29CX LogD: 0.92
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.76Np Likeness Score: -1.28

References

1. Heffernan MLR, Herman LW, Brown S, Jones PG, Shao L, Hewitt MC, Campbell JE, Dedic N, Hopkins SC, Koblan KS, Xie L..  (2022)  Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia.,  13  (1.0): [PMID:35047111] [10.1021/acsmedchemlett.1c00527]

Source